Royal Bank of Canada’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-115
| Closed | – | – | 7909 |
|
|
2023
Q3 | $0 | Hold |
115
| – | – | ﹤0.01% | 7975 |
|
|
2023
Q2 | $0 | Sell |
115
-1
| -0.9% | -$6 | ﹤0.01% | 7955 |
|
|
2023
Q1 | $1K | Hold |
116
| – | – | ﹤0.01% | 6993 |
|
|
2022
Q4 | $2K | Hold |
116
| – | – | ﹤0.01% | 6976 |
|
|
2022
Q3 | $3K | Hold |
116
| – | – | ﹤0.01% | 6960 |
|
|
2022
Q2 | $3K | Sell |
116
-67
| -37% | -$3.05K | ﹤0.01% | 6893 |
|
|
2022
Q1 | $13K | Buy |
183
+67
| +58% | +$5.26K | ﹤0.01% | 6860 |
|
|
2021
Q4 | $13K | Hold |
116
| – | – | ﹤0.01% | 6986 |
|
|
2021
Q3 | $14K | Hold |
116
| – | – | ﹤0.01% | 6856 |
|
|
2021
Q2 | $15K | Hold |
116
| – | – | ﹤0.01% | 6721 |
|
|
2021
Q1 | $18K | Buy |
116
+91
| +364% | +$16.5K | ﹤0.01% | 6498 |
|
|
2020
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 6825 |
|
|
2020
Q3 | $3K | Sell |
25
-92
| -79% | -$18.6K | ﹤0.01% | 6273 |
|
|
2020
Q2 | $25K | Hold |
117
| – | – | ﹤0.01% | 5498 |
|
|
2020
Q1 | $9K | Hold |
117
| – | – | ﹤0.01% | 5871 |
|
|
2019
Q4 | $10K | Hold |
117
| – | – | ﹤0.01% | 6154 |
|
|
2019
Q3 | $28K | Hold |
117
| – | – | ﹤0.01% | 5363 |
|
|
2019
Q2 | $39K | Hold |
117
| – | – | ﹤0.01% | 5407 |
|
|
2019
Q1 | $40K | Hold |
117
| – | – | ﹤0.01% | 5298 |
|
|
2018
Q4 | $30K | Buy |
117
+92
| +368% | +$46.2K | ﹤0.01% | 5388 |
|
|
2018
Q3 | $21K | Sell |
25
-92
| -79% | -$117K | ﹤0.01% | 5664 |
|
|
2018
Q2 | $210K | Hold |
117
| – | – | ﹤0.01% | 4381 |
|
|
2018
Q1 | $310K | Hold |
117
| – | – | ﹤0.01% | 4042 |
|
|
2017
Q4 | $729K | Buy |
+117
| New | +$925K | ﹤0.01% | 3490 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6648 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6863 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6539 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6846 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6641 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6585 |
|
Royal Bank of Canada's BIOC Position: Q4 2023 in Review
Royal Bank of Canada sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 115 shares.
Royal Bank of Canada first reported a position in BIOC in Q4 2017 and held it in 24 quarters. The position peaked at $729K in Q4 2017. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- Royal Bank of Canada reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- Royal Bank of Canada sold 115 Biocept, Inc. shares in Q4 2023.
- Royal Bank of Canada first reported a position in Biocept, Inc. in Q4 2017 and held it in 24 quarters.
- Royal Bank of Canada's Biocept, Inc. position peaked at $729K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.